Showing results (51-60 of 138) with videos related to
Sort By:
Pageof 14
Science Translational Medicine|December 14, 2018
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activationPraveen K Bommareddy, Salvatore Aspromonte, Andrew Zloza, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lungSusan Varghese, Samuel D Rabkin, Petur G Nielsen, et al.Advances in Experimental Medicine and Biology|January 5, 2010
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Alberto L Epstein, et al.Current Gene Therapy|October 28, 2005
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapyAlberto L Epstein, Peggy Marconi, Rafaela Argnani, et al.Expert Opinion on Biological Therapy|August 2, 2007
HSV-1 amplicon vectors: a promising and versatile tool for gene deliveryDelphine Cuchet, Corinne Potel, Joélle Thomas, et al.The Journal of Gene Medicine|April 27, 2005
Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo proteinDelphine Cuchet, René Ferrera, Patrick Lomonte, et al.Journal of Visualized Experiments : Jove|May 31, 2021
Growth, Purification, and Titration of Oncolytic Herpes Simplex VirusHong-My Nguyen, Naresh Sah, Melissa R M Humphrey, et al.Methods and Protocols|June 25, 2026
Triple-Survival Stereotactic Brain Surgeries for the Intracranial Injections of Glioblastoma Stem-like Cells and Oncolytic Herpes Simplex VirusesSourav Chakraborty, Connor Howard, Checo J Rorie, et al.Journal of Biological Methods|May 25, 2019
Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastomaPraveen K Bommareddy, Devin B Lowe, Howard L Kaufman, et al.Gene Therapy|November 12, 2024
Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an updateMatthieu Le Hars, Charles Joussain, Teddy Jégu, et al.Pageof 14